Form 4: Halliburton Executive Jill D. Sharp Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Jill D. Sharp, SVP Internal Assurance Services at Halliburton, reports acquiring 13,876 shares of common stock at $25.01 on January 7, 2025, increasing her direct holdings to 49,275.476 shares.

Summary

  • On January 7, 2025, Jill D. Sharp, a Senior Vice President at Halliburton, acquired 13,876 shares of Halliburton common stock at a price of $25.01 per share.
  • This acquisition increased her direct ownership to 49,275.476 shares.
  • The shares were issued on March 3, 2025, upon achievement of performance criteria and vesting of performance share units granted on January 3, 2022, under the Halliburton Company Performance Unit Program.
  • Sharp also holds options to buy 16,733 shares at $49.61 (exercisable from January 2, 2018, expiring January 2, 2028) and 14,197 shares at $55.68 (exercisable from January 3, 2017, expiring January 3, 2027).

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of an insider transaction. The acquisition itself can be seen as slightly positive, but the document is primarily informational.

Positives

  • The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. This Form 4 filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

  • Comparing Halliburton's executive compensation and equity ownership to peers like Schlumberger and Baker Hughes would provide a broader context.
  • Analyzing the vesting schedules and performance metrics of Halliburton's performance share units against industry norms can reveal how the company incentivizes its executives.

Stakeholder Impact

  • Shareholders may view the executive's stock acquisition as a positive signal.
  • The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
01/03/2017Date options to buy common stock at $55.68 became exercisable
01/02/2018Date options to buy common stock at $49.61 became exercisable
01/03/2022Date of grant for performance share units
01/07/2025Date of common stock acquisition
03/03/2025Date shares of common stock were issued upon vesting of performance share units
03/05/2025Date of signature on the Form 4
01/03/2027Expiration date for options to buy common stock at $55.68
01/02/2028Expiration date for options to buy common stock at $49.61

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.